MCRB
Seres Therapeutics, Inc.
$7.74
-0.20 (-2.52%)
At close · Jul 2
Market Cap
$74.24M
Shares
9,592,326
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$7.74
Open$7.95
Day$7.48–8.06
52W$5.31–29.98
Avg vol 30d93K
Short int220K · 2.3% float · 2.2d
Short vol42%
Last earningsMay 5, 2026
DataJan 2020–Jul 2026
Filing10-Q · May 5
Equibles Rating
blended score · not investment advice
Overall
Neutral
Technical · trend & momentum
Neutral
◦
50 / 200-day cross
no cross
−
Price vs 200-day avg
−39% below
+
Price vs 50-day avg
+6% above
◦
RSI (14)
60 · neutral
+
MACD trend
positive
−
52-week position
10% · near low
Sentiment · smart money
Bearish
◦
Trend (MA cross)
50d $7 › 200d $13 — 200d above 50d
−
Institutional flow
-11% holders QoQ · +5 funds added
−
Insider flow
Net -$3.6K over 90 days · 100% sells
+
Short interest
2.29% of float · ▼ -54.1% MoM · 2.2 days cover
◦
Volume signal
Volume near normal
◦
Institution breadth
34 holders — mid 1-yr range
Fundamentals
Fair
+
Free cash flow
$865.0K
−
Balance sheet
net debt $64.2M
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Up next
Next earnings call
Aug 4, 2026
Est · unconfirmed
· in 4 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 5, 2026
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
no cross
Neutral
Price vs 200-day avg
−39% below
Bearish
Price vs 50-day avg
+6% above
Bullish
RSI (14)
60 · neutral
Neutral
MACD trend
positive
Bullish
52-week position
10% · near low
Bearish
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross)
No cross
50d $7 › 200d $13 — 200d above 50d
Institutional flow
Distributing
-11% holders QoQ · +5 funds added
Insider flow
Distributing
Net -$3.6K over 90 days · 100% sells
Short interest
Falling
2.29% of float · ▼ -54.1% MoM · 2.2 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
34 holders — mid 1-yr range
Price context
position in its 52-week range
52-wk low $5
Now $8 · 10%
52-wk high $30
vs 200-day avg -39%
vs 50-day avg +6%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
MCRB
this stock
Seres Therapeutics, Inc.
|
$74.24M | -48.0% | -95.0% | — | 2.3% |
|
AKTX
Akari Therapeutics Plc
|
$953.21B | -9.9% | — | — | 0.0% |
|
ONC
BeOne Medicines Ltd.
|
$470.30B | -2.0% | +22179.2% | 957.1 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$134.02B | +16.5% | +46.2% | 31.3 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$69.80B | -15.1% | +20.8% | 16.3 | 3.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| MCRB | +13.1% | +8.0% | -49.9% | -1.9% | -48.0% |
| SPY | +1.4% | -1.3% | +8.0% | -0.3% | +9.2% |
| vs SPY | +11.7% | +9.2% | -57.9% | -1.6% | -57.2% |